TP53 and diffuse large B-cell lymphoma: Hotspot mutations but not non-hotspot mutations were strongly associated with lower CR rate and shorter PFS in DLBCL patients, and were previously shown to affect the DNA-binding activity of the p53 protein, thereby impairing the regulation of target genes (24, 25).